Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1244]
News [2385]
Articles [91]
Editorials [4]
Conferences [117]
elearning [25]
Osteoporosis and osteopenia in elderly patients
Dr Matti Aapro - Genolier Cancer Center, Genolier, Switzerland
Osteoporosis and osteopenia in elderly patients ( Dr Matti Aapro - Genolier Cancer Center, Genolier, Switzerland )
22 Nov 2018
The emerging era of no-completion lymph node dissection
Dr Daniel Coit - Memorial Sloan Kettering Cancer Centre, New York, USA
The emerging era of no-completion lymph node dissection ( Dr Daniel Coit - Memorial Sloan Kettering Cancer Centre, New York, USA )
20 Nov 2018
Do we still need surgery in advanced melanoma?
Prof John Thompson - University of Sydney, Sydney, Australia
Do we still need surgery in advanced melanoma? ( Prof John Thompson - University of Sydney, Sydney, Australia )
20 Nov 2018
Combination strategies of immunotherapy in breast cancer
Prof Guiseppe Curigliano - European Institute of Oncology, Milan, Italy
Combination strategies of immunotherapy in breast cancer ( Prof Guiseppe Curigliano - European Institute of Oncology, Milan, Italy )
26 Oct 2018
ABOUND.sqm: nab-paclitaxel and carboplatin induction followed by nab-paclitaxel...
Dr David R. Spigel - Tennessee Oncology, Nashville, USA
ABOUND.sqm: nab-paclitaxel and carboplatin induction followed by nab-paclitaxel maintenance in NSCLC ( Dr David R. Spigel - Tennessee Oncology, Nashville, USA )
26 Oct 2018
ASCEND-8: safety data of ceritinib with or without food in NSCLC
Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, Republic of Korea
ASCEND-8: safety data of ceritinib with or without food in NSCLC ( Prof Byoung Chul Cho - Yonsei Cancer Center, Seoul, Republic of Korea )
26 Oct 2018
IMpower132: atezolizumab, carboplatin and pemetrexed as first line treatment in...
Dr Fabrice Barlesi - Aix-Marseille University, Marseille, France
IMpower132: atezolizumab, carboplatin and pemetrexed as first line treatment in key subgroups with stage IV non-squamous NSCLC ( Dr Fabrice Barlesi - Aix-Marseille University, Marseille, France )
25 Oct 2018
Cardiac events in stage III NSCLC treated in daily clinical practice
Dr Juliette Degens - Academisch Ziekenhuis Maastricht, Maastricht, Netherlands
Cardiac events in stage III NSCLC treated in daily clinical practice ( Dr Juliette Degens - Academisch Ziekenhuis Maastricht, Maastricht, Netherlands )
25 Oct 2018
KEYNOTE022: Triplet therapy for BRAF melanoma
Prof Paolo Ascierto - Istituto Nazionale Tumori - IRCCS "Fondazione G.Pascale"...
KEYNOTE022: Triplet therapy for BRAF melanoma ( Prof Paolo Ascierto - Istituto Nazionale Tumori - IRCCS "Fondazione G.Pascale", Milan, Italy )
22 Oct 2018
SPLENDOUR: Added denosumab in first line adv NSCLC treatment
Dr Solange Peters - Centre Hospitalier Universitaire Vaudois, Lausanne...
SPLENDOUR: Added denosumab in first line adv NSCLC treatment ( Dr Solange Peters - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland )
22 Oct 2018
Cisplatin superior to cetuximab for HPV oropharyngeal cancer
Prof Hisham Mehanna - University of Birmingham , Birmingham, UK
Cisplatin superior to cetuximab for HPV oropharyngeal cancer ( Prof Hisham Mehanna - University of Birmingham , Birmingham, UK )
22 Oct 2018
Cisplatin v cetuximab for HPV associated oropharyngeal cancer
Prof Hisham Mehanna - University of Birmingham , Birmingham, UK
Cisplatin v cetuximab for HPV associated oropharyngeal cancer ( Prof Hisham Mehanna - University of Birmingham , Birmingham, UK )
22 Oct 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation